144 related articles for article (PubMed ID: 33661067)
1. Epidemiology and Clinical Characteristics of Presumed Ocular Histoplasmosis in Olmsted County, Minnesota.
Xu TT; Reynolds MM; Hodge DO; Smith WM
Ocul Immunol Inflamm; 2022 Jul; 30(5):1039-1043. PubMed ID: 33661067
[TBL] [Abstract][Full Text] [Related]
2. Smoking as a risk factor for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
Chheda LV; Ferketich AK; Carroll CP; Moyer PD; Kurz DE; Kurz PA
Ophthalmology; 2012 Feb; 119(2):333-8. PubMed ID: 22035582
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of surgical removal of extensive peripapillary choroidal neovascularization in presumed ocular histoplasmosis syndrome.
Almony A; Thomas MA; Atebara NH; Holekamp NM; Del Priore LV
Ophthalmology; 2008 Mar; 115(3):540-545.e5. PubMed ID: 17988741
[TBL] [Abstract][Full Text] [Related]
4. [Presumed ocular histoplasmosis syndrome (POHS)].
Laghmari M; Lezrek O
Pan Afr Med J; 2014; 18():268. PubMed ID: 25426215
[No Abstract] [Full Text] [Related]
5. INTRAVITREAL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO OCULAR HISTOPLASMOSIS: Ten-Year Follow-Up.
Dudenhoefer NE; Noble CW; Petersen MR; Foster RE; Riemann CD; Sisk RA; Hutchins RK; Miller DM
Retina; 2022 Aug; 42(8):1568-1573. PubMed ID: 35877968
[TBL] [Abstract][Full Text] [Related]
6. SMOKING, RURAL RESIDENCE AND DIABETES AS RISK FACTORS FOR PRESUMED OCULAR HISTOPLASMOSIS SYNDROME.
Richey BF; Obrock RS; Gee ZM; Lu DY; Jacobsen G; Richards SC
Retina; 2022 Feb; 42(2):369-374. PubMed ID: 34690340
[TBL] [Abstract][Full Text] [Related]
7. Presumed ocular histoplasmosis syndrome in India.
Sinha R; Raju S; Garg SP; Venkatesh P; Talwar D
Ocul Immunol Inflamm; 2007; 15(4):315-7. PubMed ID: 17763129
[TBL] [Abstract][Full Text] [Related]
8. Surgical removal of extensive peripapillary choroidal neovascularization associated with presumed ocular histoplasmosis syndrome.
Atebara NH; Thomas MA; Holekamp NM; Mandell BA; Del Priore LV
Ophthalmology; 1998 Sep; 105(9):1598-605. PubMed ID: 9754163
[TBL] [Abstract][Full Text] [Related]
9. Presumed ocular histoplasmosis syndrome in a commercially insured population, United States.
Benedict K; Shantha JG; Yeh S; Beer KD; Jackson BR
PLoS One; 2020; 15(3):e0230305. PubMed ID: 32168355
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy for subfoveal classic choroidal neovascularization related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like).
Postelmans L; Pasteels B; Coquelet P; Caspers L; Verougstraete C; Leys A; Wirix M; Mauget-Faÿsse M; Quanranta M; Snyers B; Smets E
Ocul Immunol Inflamm; 2005; 13(5):361-6. PubMed ID: 16419421
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
Ehrlich R; Ciulla TA; Maturi R; Kheradiya NS; Hrisomalos N; Shulman S; Guess MG; Coyle E; Harris A
Retina; 2009; 29(10):1418-23. PubMed ID: 19898179
[TBL] [Abstract][Full Text] [Related]
12. Choroidal neovascularization after laser in situ keratomileusis in a patient with presumed ocular histoplasmosis syndrome.
Fedorovich I; Mehr DS; Oz O; Akduman L
Eur J Ophthalmol; 2004; 14(3):261-3. PubMed ID: 15206653
[TBL] [Abstract][Full Text] [Related]
13. Analysis of outcomes for intravitreal bevacizumab in the treatment of choroidal neovascularization secondary to ocular histoplasmosis.
Cionni DA; Lewis SA; Petersen MR; Foster RE; Riemann CD; Sisk RA; Hutchins RK; Miller DM
Ophthalmology; 2012 Feb; 119(2):327-32. PubMed ID: 22133795
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab as initial treatment for choroidal neovascularization associated with presumed ocular histoplasmosis syndrome.
Adán A; Navarro M; Casaroli-Marano RP; Ortiz S; Molina JJ
Graefes Arch Clin Exp Ophthalmol; 2007 Dec; 245(12):1873-5. PubMed ID: 17786466
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal anti-vascular endothelial growth factor for choroidal neovascularization in ocular histoplasmosis.
Hu J; Hoang QV; Chau FY; Blair MP; Lim JI
Retin Cases Brief Rep; 2014; 8(1):24-9. PubMed ID: 25372202
[TBL] [Abstract][Full Text] [Related]
16. The development of choroidal neovascularization in pregnancy.
Rhee P; Dev S; Mieler WF
Retina; 1999; 19(6):520-4. PubMed ID: 10606452
[TBL] [Abstract][Full Text] [Related]
17. INTRAVITREAL AFLIBERCEPT INJECTION FOR CHOROIDAL NEOVASCULARIZATION DUE TO PRESUMED OCULAR HISTOPLASMOSIS SYNDROME: The HANDLE Study.
Toussaint BW; Kitchens JW; Marcus DM; Miller DM; Kingdon ML; Holcomb D; Ivey K
Retina; 2018 Apr; 38(4):755-763. PubMed ID: 28333879
[TBL] [Abstract][Full Text] [Related]
18. Ocular histoplasmosis syndrome.
Diaz RI; Sigler EJ; Rafieetary MR; Calzada JI
Surv Ophthalmol; 2015; 60(4):279-95. PubMed ID: 25841248
[TBL] [Abstract][Full Text] [Related]
19. Surgical removal of subfoveal choroidal neovascularization in presumed ocular histoplasmosis: stability of early visual results.
Holekamp NM; Thomas MA; Dickinson JD; Valluri S
Ophthalmology; 1997 Jan; 104(1):22-6. PubMed ID: 9022099
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab for choroidal neovascularization in ocular histoplasmosis.
Schadlu R; Blinder KJ; Shah GK; Holekamp NM; Thomas MA; Grand MG; Engelbrecht NE; Apte RS; Joseph DP; Prasad AG; Smith BT; Sheybani A
Am J Ophthalmol; 2008 May; 145(5):875-8. PubMed ID: 18321466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
